Wockhardt Ltd. is an Indian-based global pharmaceutical and biotechnology company founded by Dr. Habil Khorakiwala in 1967, focusing on pharmaceuticals, biotechnology, active pharmaceutical ingredients (APIs), and a chain of super specialty hospitals. The company has a global presence in India, the US, and Europe, with its primary business being the development and manufacture of affordable, high-quality medicines, biosimilars, and novel drug delivery systems, particularly noted for its research in anti-infectives and diabetes care.